Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVejle Hospital
About this trial
The purpose of this study is to examine the effect of supplementary polyunsaturated fatty acids on nerve damage in the body's extremitites of patients treated with oxaliplatin containing chemotherapy after surgery for colorectal cancer.
Eligibility criteria
Qualifiers
Histopathologically verified adenocarcinoma of the colon or rectum and planned standard adjuvant treatment with capecitabine in combination with oxaliplatin.
ECOG performance status 0-2 (measurement of a patient's function in terms of self-care, daily activity and physical ability.
Written and orally informed informed consent
Disqualifiers
Inability to speak, read, and understand Danish.
Previous treatment with neurotoxic chemotherapy.
Neurological (including neuropathy) or psychiatric disorders, diabetes or other significant medical conditions.
Alcohol or drug abuse.
Trial design
Treatments tested in this trial
- Fish oil
- Corn oil
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov